408 related articles for article (PubMed ID: 9241108)
41. Prophylaxis and treatment of Pneumocystis carinii pneumonia.
O'Doherty MJ; Bateman NT
Br J Hosp Med; 1991 May; 45(5):277-8, 280, 283. PubMed ID: 1676607
[TBL] [Abstract][Full Text] [Related]
42. Predictive value of bronchoalveolar lavage in excluding a diagnosis of Pneumocystis carinii pneumonia during prophylaxis with aerosolized pentamidine.
Teuscher AU; Opravil M; Theiler R; Speich R; Kuster H; Siegenthaler W; Russi EW; Lüthy R
Clin Infect Dis; 1993 Apr; 16(4):519-22. PubMed ID: 8513058
[TBL] [Abstract][Full Text] [Related]
43. Failure of intravenous pentamidine prophylaxis for Pneumocystis carinii pneumonia.
Weintrub PS; Wara DW; Duliege AM
J Pediatr; 1993 Jan; 122(1):163-4. PubMed ID: 8419606
[No Abstract] [Full Text] [Related]
44. How to interpret an overview: a meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.
Easterbrook PJ
Genitourin Med; 1997 Apr; 73(2):139-43. PubMed ID: 9215100
[No Abstract] [Full Text] [Related]
45. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC
N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145
[TBL] [Abstract][Full Text] [Related]
46. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.
Hardy WD; Feinberg J; Finkelstein DM; Power ME; He W; Kaczka C; Frame PT; Holmes M; Waskin H; Fass RJ
N Engl J Med; 1992 Dec; 327(26):1842-8. PubMed ID: 1448121
[TBL] [Abstract][Full Text] [Related]
47. Experimental evaluation of combined prophylaxis against murine pneumocystosis and toxoplasmosis.
Brun-Pascaud M; Chau F; Simonpoli AM; Girard PM; Derouin F; Pocidalo JJ
J Infect Dis; 1994 Sep; 170(3):653-8. PubMed ID: 8077724
[TBL] [Abstract][Full Text] [Related]
48. Pneumocystis carinii pneumonia: therapy and prophylaxis.
Kovacs JA; Masur H
J Infect Dis; 1988 Jul; 158(1):254-9. PubMed ID: 2969023
[No Abstract] [Full Text] [Related]
49. Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus.
Opravil M; Pechère M; Lazzarin A; Heald A; Rüttimann S; Iten A; Furrer H; Oertle D; Praz G; Vuitton DA
Clin Infect Dis; 1995 Feb; 20(2):244-9. PubMed ID: 7742423
[TBL] [Abstract][Full Text] [Related]
50. Prevention of infection due to Pneumocystis carinii.
Fishman JA
Antimicrob Agents Chemother; 1998 May; 42(5):995-1004. PubMed ID: 9593116
[No Abstract] [Full Text] [Related]
51. A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
Martin MA; Cox PH; Beck K; Styer CM; Beall GN
Arch Intern Med; 1992 Mar; 152(3):523-8. PubMed ID: 1546914
[TBL] [Abstract][Full Text] [Related]
52. Prevention of Pneumocystis carinii pneumonia.
Med Lett Drugs Ther; 1988 Oct; 30(776):94-5. PubMed ID: 3050408
[No Abstract] [Full Text] [Related]
53. Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial. The Italian PCP Study Group.
Rizzardi GP; Lazzarin A; Musicco M; Frigerio D; Maillard M; Lucchini M; Moroni M
J Infect; 1996 Mar; 32(2):123-31. PubMed ID: 8708369
[TBL] [Abstract][Full Text] [Related]
54. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.
Carr A; Tindall B; Penny R; Cooper DA
AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714
[TBL] [Abstract][Full Text] [Related]
55. Pneumocystis carinii pneumonia treatment in people infected with HIV.
Bellamy R
Clin Evid; 2004 Jun; (11):935-50. PubMed ID: 15652046
[No Abstract] [Full Text] [Related]
56. Aerosolized pentamidine in HIV. Promising new treatment for Pneumocystis carinii pneumonia.
Sarti GM
Postgrad Med; 1989 Aug; 86(2):54-6, 59-60, 63, passim. PubMed ID: 2666972
[TBL] [Abstract][Full Text] [Related]
57. Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection.
Gupta M; Stephenson K; Gauar S; Frenkel L
Pediatr Pulmonol Suppl; 1997; 16():199-200. PubMed ID: 9443273
[No Abstract] [Full Text] [Related]
58. [Therapy and prevention of pneumocystis carinii pneumonia].
Goebel FD; Bogner JR
Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220
[No Abstract] [Full Text] [Related]
59. Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis.
Antinori A; Murri R; Ammassari A
AIDS; 1996 Aug; 10(9):1046-7. PubMed ID: 8853743
[No Abstract] [Full Text] [Related]
60. Bilateral upper-lobe cavitary Pneumocystis carinii pneumonia in a patient on dapsone prophylaxis.
Jawahar DA; Dama S; Miarrostami R; Sadagdhar H; Anandarao N
Am J Med Sci; 1999 Feb; 317(2):137-9. PubMed ID: 10037118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
